Updated:
Changrong Capital
Changrong Capital is a venture capital firm based in China. It focuses on investments in healthcare, environmental protection, non-ferrous metals, cultural &...
Overview
Changrong Capital is a venture capital firm based in China. It focuses on investments in healthcare, environmental protection, non-ferrous metals, cultural & creative industries, TMT, and artificial intelligence. The firm has made 20 investments, including a Series A investment in Amberstone Biosciences on January 03, 2022.
General information
Firm type
Asset Manager
Year founded
2007
Location
Region
Asia
Country
China
City
厦门
Corporate office
Shenzhen, China
Additional offices
Xiamen, China · Hong Kong, China · Chongqing, China · Sunnyvale, United States
Sector focus
Frequently asked questions
Who makes investment decisions at Changrong Capital?
The firm does not publicly identify its investment decision-makers. No named principals or executives appear in public records, filings, or media reports. This level of opacity is common among certain Chinese family offices and asset managers that operate without a public marketing presence.
Where does Changrong Capital invest?
The firm's office locations—Shenzhen, Xiamen, Hong Kong, Chongqing, and Sunnyvale—suggest a dual focus on the Chinese domestic market and US technology investments. Sunnyvale, California, positions the firm within proximity to Silicon Valley venture ecosystems. Exact sector or stage preferences are not documented.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: